From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer

Rangachari, Deepa; Costa, Daniel B

doi:10.1200/JCO.19.01207

Record: found
Abstract: not found
Article: not found

From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer

Author(s): Deepa Rangachari ¹ , Daniel B. Costa ¹

Publication date Created: October 01 2019

Publication date (Print): October 01 2019

Journal: Journal of Clinical Oncology

Publisher: American Society of Clinical Oncology (ASCO)

Read this article at

ScienceOpenPublisher PMC

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Most cited references 4

Record: found
Abstract: found
Article: not found

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan … (2015)

Brain metastases (BM) are common in non-small-cell lung cancer (NSCLC). However, the baseline incidence and evolution of BM over time in oncogene-driven NSCLCs are seldom reported. In this study, we evaluated the frequency of BM in patients with epidermal growth factor receptor (EGFR)-mutated or anaplastic lymphoma kinase (ALK)-rearranged NSCLC.

0 comments Cited 193 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Natural history and factors associated with overall survival in stage IV ALK rearranged non-small-cell lung cancer

J.M. Pacheco, D. Gao, D. Smith … (2018)

Clinical variables describing the natural history and longitudinal therapy outcomes of stage IV anaplastic lymphoma kinase gene rearrangement positive (ALK-positive) NSCLC and their relationship with long-term overall survival (OS) have not previously been described in detail.